Cargando…
Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis
Autores principales: | Moore, Andrew R., Boyce, Malcolm, Steele, Islay A., Campbell, Fiona, Varro, Andrea, Pritchard, D. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815352/ http://dx.doi.org/10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116 |
Ejemplares similares
-
Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis
por: Moore, Andrew R., et al.
Publicado: (2013) -
Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors
por: Lloyd, Katie A., et al.
Publicado: (2020) -
The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis
por: Wang, Xu, et al.
Publicado: (2016) -
Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics
por: Broutet, N, et al.
Publicado: (2003) -
Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects
por: Dondov, Ganchimeg, et al.
Publicado: (2022)